BlackRock Health Sciences Trust II
BMEZ · NYSE
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $191 | $215 | $204 | $229 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $1 | $0 | $0 |
| Enterprise Value | $191 | $216 | $204 | $229 |
| Revenue | $24 | -$0 | $18 | $17 |
| % Growth | 6,471% | -102.1% | 10.1% | – |
| Gross Profit | $28 | -$3 | $15 | $14 |
| % Margin | 112.6% | 904% | 83.5% | 81.9% |
| EBITDA | -$22 | $46 | $9 | $11 |
| % Margin | -91.9% | -11,976.7% | 47.6% | 68.1% |
| Net Income | -$22 | $46 | $9 | $11 |
| % Margin | -92% | -11,969.7% | 47.6% | 68.1% |
| EPS Diluted | -1.53 | 3.3 | 0.62 | 0.81 |
| % Growth | -146.4% | 432.3% | -23.5% | – |
| Operating Cash Flow | $79 | -$13 | -$2 | $7 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | $79 | -$13 | -$2 | $7 |